Pharma & Healthcare
Global Radiopharmaceutical Market Research Report 2025
- Mar 11, 25
- ID: 27759
- Pages: 90
- Figures: 90
- Views: 15
The global market for Radiopharmaceutical was valued at US$ 6678 million in the year 2024 and is projected to reach a revised size of US$ 10850 million by 2031, growing at a CAGR of 7.3% during the forecast period.
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
The radiopharmaceutical market is driven primarily by the growing prevalence of cancer and cardiovascular diseases, which require precise diagnostic tools for early detection and treatment. The increasing adoption of nuclear medicine imaging techniques, such as PET and SPECT scans, has further fueled demand for radiopharmaceuticals. Additionally, technological advancements in radiopharmaceuticals, along with the development of new radioisotopes for more targeted therapies, are expanding the applications of these drugs, making them critical in personalized medicine.
Despite the promising growth, the radiopharmaceutical market faces significant challenges, including the high cost of production and the short half-life of many radioisotopes, which complicates distribution and storage. Regulatory hurdles are another barrier, as radiopharmaceuticals require stringent approval processes due to their radioactive nature. Moreover, limited availability of specialized infrastructure and the shortage of trained professionals in nuclear medicine also hinder widespread adoption, especially in developing regions.
There is widespread awareness of the use of radiation and radioisotopes in medicine, particularly for diagnosis (identification) and therapy (treatment) of various medical conditions. In developed countries (a quarter of the world population) about one person in 50 uses diagnostic nuclear medicine each year, and the frequency of therapy with radioisotopes is about one-tenth of this.
Nuclear medicine uses radiation to provide information about the functioning of a person's specific organs, or to treat disease. In most cases, the information is used by physicians to make a quick diagnosis of the patient's illness. The thyroid, bones, heart, liver, and many other organs can be easily imaged, and disorders in their function revealed. In some cases radiation can be used to treat diseased organs, or tumours.
Over 10,000 hospitals worldwide use radioisotopes in medicine, and about 90% of the procedures are for diagnosis. The most common radioisotope used in diagnosis is technetium-99 (Tc-99m) accounting for about 80% of all nuclear medicine procedures and 85% of diagnostic scans in nuclear medicine worldwide.Over 50 million nuclear medicine procedures are performed each year, and demand for radioisotopes is increasing.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Radiopharmaceutical, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radiopharmaceutical.
The Radiopharmaceutical market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Radiopharmaceutical market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Radiopharmaceutical manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Cardinal Health
GE Healthcare
Jubilant Pharma
Novartis
Curium Pharma
SIEMENS
Lantheus
Bracco Imaging
Bayer
Eli Lilly
Aurobindo Pharma
Mundipharma
China Isotope & Radiation
Dongcheng
Segment by Type
Diagnostic Radiopharmaceuticals
Therapeutic Radiopharmaceuticals
Segment by Application
Oncology
Cardiology
Other
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Radiopharmaceutical manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Radiopharmaceutical in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
The radiopharmaceutical market is driven primarily by the growing prevalence of cancer and cardiovascular diseases, which require precise diagnostic tools for early detection and treatment. The increasing adoption of nuclear medicine imaging techniques, such as PET and SPECT scans, has further fueled demand for radiopharmaceuticals. Additionally, technological advancements in radiopharmaceuticals, along with the development of new radioisotopes for more targeted therapies, are expanding the applications of these drugs, making them critical in personalized medicine.
Despite the promising growth, the radiopharmaceutical market faces significant challenges, including the high cost of production and the short half-life of many radioisotopes, which complicates distribution and storage. Regulatory hurdles are another barrier, as radiopharmaceuticals require stringent approval processes due to their radioactive nature. Moreover, limited availability of specialized infrastructure and the shortage of trained professionals in nuclear medicine also hinder widespread adoption, especially in developing regions.
There is widespread awareness of the use of radiation and radioisotopes in medicine, particularly for diagnosis (identification) and therapy (treatment) of various medical conditions. In developed countries (a quarter of the world population) about one person in 50 uses diagnostic nuclear medicine each year, and the frequency of therapy with radioisotopes is about one-tenth of this.
Nuclear medicine uses radiation to provide information about the functioning of a person's specific organs, or to treat disease. In most cases, the information is used by physicians to make a quick diagnosis of the patient's illness. The thyroid, bones, heart, liver, and many other organs can be easily imaged, and disorders in their function revealed. In some cases radiation can be used to treat diseased organs, or tumours.
Over 10,000 hospitals worldwide use radioisotopes in medicine, and about 90% of the procedures are for diagnosis. The most common radioisotope used in diagnosis is technetium-99 (Tc-99m) accounting for about 80% of all nuclear medicine procedures and 85% of diagnostic scans in nuclear medicine worldwide.Over 50 million nuclear medicine procedures are performed each year, and demand for radioisotopes is increasing.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Radiopharmaceutical, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radiopharmaceutical.
The Radiopharmaceutical market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Radiopharmaceutical market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Radiopharmaceutical manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Cardinal Health
GE Healthcare
Jubilant Pharma
Novartis
Curium Pharma
SIEMENS
Lantheus
Bracco Imaging
Bayer
Eli Lilly
Aurobindo Pharma
Mundipharma
China Isotope & Radiation
Dongcheng
Segment by Type
Diagnostic Radiopharmaceuticals
Therapeutic Radiopharmaceuticals
Segment by Application
Oncology
Cardiology
Other
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Radiopharmaceutical manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Radiopharmaceutical in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Radiopharmaceutical Market Overview
1.1 Product Definition
1.2 Radiopharmaceutical by Type
1.2.1 Global Radiopharmaceutical Market Value Comparison by Type (2024 VS 2031)
1.2.2 Diagnostic Radiopharmaceuticals
1.2.3 Therapeutic Radiopharmaceuticals
1.3 Radiopharmaceutical by Application
1.3.1 Global Radiopharmaceutical Market Value by Application (2024 VS 2031)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Global Radiopharmaceutical Market Size Estimates and Forecasts
1.4.1 Global Radiopharmaceutical Revenue 2020-2031
1.4.2 Global Radiopharmaceutical Sales 2020-2031
1.4.3 Global Radiopharmaceutical Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Radiopharmaceutical Market Competition by Manufacturers
2.1 Global Radiopharmaceutical Sales Market Share by Manufacturers (2020-2025)
2.2 Global Radiopharmaceutical Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Radiopharmaceutical Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Radiopharmaceutical, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Radiopharmaceutical, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Radiopharmaceutical, Product Type & Application
2.7 Global Key Manufacturers of Radiopharmaceutical, Date of Enter into This Industry
2.8 Global Radiopharmaceutical Market Competitive Situation and Trends
2.8.1 Global Radiopharmaceutical Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Radiopharmaceutical Players Market Share by Revenue
2.8.3 Global Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Radiopharmaceutical Market Scenario by Region
3.1 Global Radiopharmaceutical Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Radiopharmaceutical Sales by Region: 2020-2031
3.2.1 Global Radiopharmaceutical Sales by Region: 2020-2025
3.2.2 Global Radiopharmaceutical Sales by Region: 2026-2031
3.3 Global Radiopharmaceutical Revenue by Region: 2020-2031
3.3.1 Global Radiopharmaceutical Revenue by Region: 2020-2025
3.3.2 Global Radiopharmaceutical Revenue by Region: 2026-2031
3.4 North America Radiopharmaceutical Market Facts & Figures by Country
3.4.1 North America Radiopharmaceutical Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Radiopharmaceutical Sales by Country (2020-2031)
3.4.3 North America Radiopharmaceutical Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Radiopharmaceutical Market Facts & Figures by Country
3.5.1 Europe Radiopharmaceutical Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Radiopharmaceutical Sales by Country (2020-2031)
3.5.3 Europe Radiopharmaceutical Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Radiopharmaceutical Market Facts & Figures by Region
3.6.1 Asia Pacific Radiopharmaceutical Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Radiopharmaceutical Sales by Region (2020-2031)
3.6.3 Asia Pacific Radiopharmaceutical Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Radiopharmaceutical Market Facts & Figures by Country
3.7.1 Latin America Radiopharmaceutical Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Radiopharmaceutical Sales by Country (2020-2031)
3.7.3 Latin America Radiopharmaceutical Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Radiopharmaceutical Market Facts & Figures by Country
3.8.1 Middle East and Africa Radiopharmaceutical Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Radiopharmaceutical Sales by Country (2020-2031)
3.8.3 Middle East and Africa Radiopharmaceutical Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Radiopharmaceutical Sales by Type (2020-2031)
4.1.1 Global Radiopharmaceutical Sales by Type (2020-2025)
4.1.2 Global Radiopharmaceutical Sales by Type (2026-2031)
4.1.3 Global Radiopharmaceutical Sales Market Share by Type (2020-2031)
4.2 Global Radiopharmaceutical Revenue by Type (2020-2031)
4.2.1 Global Radiopharmaceutical Revenue by Type (2020-2025)
4.2.2 Global Radiopharmaceutical Revenue by Type (2026-2031)
4.2.3 Global Radiopharmaceutical Revenue Market Share by Type (2020-2031)
4.3 Global Radiopharmaceutical Price by Type (2020-2031)
5 Segment by Application
5.1 Global Radiopharmaceutical Sales by Application (2020-2031)
5.1.1 Global Radiopharmaceutical Sales by Application (2020-2025)
5.1.2 Global Radiopharmaceutical Sales by Application (2026-2031)
5.1.3 Global Radiopharmaceutical Sales Market Share by Application (2020-2031)
5.2 Global Radiopharmaceutical Revenue by Application (2020-2031)
5.2.1 Global Radiopharmaceutical Revenue by Application (2020-2025)
5.2.2 Global Radiopharmaceutical Revenue by Application (2026-2031)
5.2.3 Global Radiopharmaceutical Revenue Market Share by Application (2020-2031)
5.3 Global Radiopharmaceutical Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Cardinal Health
6.1.1 Cardinal Health Company Information
6.1.2 Cardinal Health Description and Business Overview
6.1.3 Cardinal Health Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Cardinal Health Radiopharmaceutical Product Portfolio
6.1.5 Cardinal Health Recent Developments/Updates
6.2 GE Healthcare
6.2.1 GE Healthcare Company Information
6.2.2 GE Healthcare Description and Business Overview
6.2.3 GE Healthcare Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GE Healthcare Radiopharmaceutical Product Portfolio
6.2.5 GE Healthcare Recent Developments/Updates
6.3 Jubilant Pharma
6.3.1 Jubilant Pharma Company Information
6.3.2 Jubilant Pharma Description and Business Overview
6.3.3 Jubilant Pharma Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Jubilant Pharma Radiopharmaceutical Product Portfolio
6.3.5 Jubilant Pharma Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Company Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novartis Radiopharmaceutical Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Curium Pharma
6.5.1 Curium Pharma Company Information
6.5.2 Curium Pharma Description and Business Overview
6.5.3 Curium Pharma Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Curium Pharma Radiopharmaceutical Product Portfolio
6.5.5 Curium Pharma Recent Developments/Updates
6.6 SIEMENS
6.6.1 SIEMENS Company Information
6.6.2 SIEMENS Description and Business Overview
6.6.3 SIEMENS Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
6.6.4 SIEMENS Radiopharmaceutical Product Portfolio
6.6.5 SIEMENS Recent Developments/Updates
6.7 Lantheus
6.7.1 Lantheus Company Information
6.7.2 Lantheus Description and Business Overview
6.7.3 Lantheus Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Lantheus Radiopharmaceutical Product Portfolio
6.7.5 Lantheus Recent Developments/Updates
6.8 Bracco Imaging
6.8.1 Bracco Imaging Company Information
6.8.2 Bracco Imaging Description and Business Overview
6.8.3 Bracco Imaging Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bracco Imaging Radiopharmaceutical Product Portfolio
6.8.5 Bracco Imaging Recent Developments/Updates
6.9 Bayer
6.9.1 Bayer Company Information
6.9.2 Bayer Description and Business Overview
6.9.3 Bayer Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Bayer Radiopharmaceutical Product Portfolio
6.9.5 Bayer Recent Developments/Updates
6.10 Eli Lilly
6.10.1 Eli Lilly Company Information
6.10.2 Eli Lilly Description and Business Overview
6.10.3 Eli Lilly Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Eli Lilly Radiopharmaceutical Product Portfolio
6.10.5 Eli Lilly Recent Developments/Updates
6.11 Aurobindo Pharma
6.11.1 Aurobindo Pharma Company Information
6.11.2 Aurobindo Pharma Description and Business Overview
6.11.3 Aurobindo Pharma Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Aurobindo Pharma Radiopharmaceutical Product Portfolio
6.11.5 Aurobindo Pharma Recent Developments/Updates
6.12 Mundipharma
6.12.1 Mundipharma Company Information
6.12.2 Mundipharma Description and Business Overview
6.12.3 Mundipharma Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Mundipharma Radiopharmaceutical Product Portfolio
6.12.5 Mundipharma Recent Developments/Updates
6.13 China Isotope & Radiation
6.13.1 China Isotope & Radiation Company Information
6.13.2 China Isotope & Radiation Description and Business Overview
6.13.3 China Isotope & Radiation Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
6.13.4 China Isotope & Radiation Radiopharmaceutical Product Portfolio
6.13.5 China Isotope & Radiation Recent Developments/Updates
6.14 Dongcheng
6.14.1 Dongcheng Company Information
6.14.2 Dongcheng Description and Business Overview
6.14.3 Dongcheng Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Dongcheng Radiopharmaceutical Product Portfolio
6.14.5 Dongcheng Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Radiopharmaceutical Industry Chain Analysis
7.2 Radiopharmaceutical Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Radiopharmaceutical Production Mode & Process Analysis
7.4 Radiopharmaceutical Sales and Marketing
7.4.1 Radiopharmaceutical Sales Channels
7.4.2 Radiopharmaceutical Distributors
7.5 Radiopharmaceutical Customer Analysis
8 Radiopharmaceutical Market Dynamics
8.1 Radiopharmaceutical Industry Trends
8.2 Radiopharmaceutical Market Drivers
8.3 Radiopharmaceutical Market Challenges
8.4 Radiopharmaceutical Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Radiopharmaceutical by Type
1.2.1 Global Radiopharmaceutical Market Value Comparison by Type (2024 VS 2031)
1.2.2 Diagnostic Radiopharmaceuticals
1.2.3 Therapeutic Radiopharmaceuticals
1.3 Radiopharmaceutical by Application
1.3.1 Global Radiopharmaceutical Market Value by Application (2024 VS 2031)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Global Radiopharmaceutical Market Size Estimates and Forecasts
1.4.1 Global Radiopharmaceutical Revenue 2020-2031
1.4.2 Global Radiopharmaceutical Sales 2020-2031
1.4.3 Global Radiopharmaceutical Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Radiopharmaceutical Market Competition by Manufacturers
2.1 Global Radiopharmaceutical Sales Market Share by Manufacturers (2020-2025)
2.2 Global Radiopharmaceutical Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Radiopharmaceutical Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Radiopharmaceutical, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Radiopharmaceutical, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Radiopharmaceutical, Product Type & Application
2.7 Global Key Manufacturers of Radiopharmaceutical, Date of Enter into This Industry
2.8 Global Radiopharmaceutical Market Competitive Situation and Trends
2.8.1 Global Radiopharmaceutical Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Radiopharmaceutical Players Market Share by Revenue
2.8.3 Global Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Radiopharmaceutical Market Scenario by Region
3.1 Global Radiopharmaceutical Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Radiopharmaceutical Sales by Region: 2020-2031
3.2.1 Global Radiopharmaceutical Sales by Region: 2020-2025
3.2.2 Global Radiopharmaceutical Sales by Region: 2026-2031
3.3 Global Radiopharmaceutical Revenue by Region: 2020-2031
3.3.1 Global Radiopharmaceutical Revenue by Region: 2020-2025
3.3.2 Global Radiopharmaceutical Revenue by Region: 2026-2031
3.4 North America Radiopharmaceutical Market Facts & Figures by Country
3.4.1 North America Radiopharmaceutical Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Radiopharmaceutical Sales by Country (2020-2031)
3.4.3 North America Radiopharmaceutical Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Radiopharmaceutical Market Facts & Figures by Country
3.5.1 Europe Radiopharmaceutical Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Radiopharmaceutical Sales by Country (2020-2031)
3.5.3 Europe Radiopharmaceutical Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Radiopharmaceutical Market Facts & Figures by Region
3.6.1 Asia Pacific Radiopharmaceutical Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Radiopharmaceutical Sales by Region (2020-2031)
3.6.3 Asia Pacific Radiopharmaceutical Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Radiopharmaceutical Market Facts & Figures by Country
3.7.1 Latin America Radiopharmaceutical Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Radiopharmaceutical Sales by Country (2020-2031)
3.7.3 Latin America Radiopharmaceutical Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Radiopharmaceutical Market Facts & Figures by Country
3.8.1 Middle East and Africa Radiopharmaceutical Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Radiopharmaceutical Sales by Country (2020-2031)
3.8.3 Middle East and Africa Radiopharmaceutical Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Radiopharmaceutical Sales by Type (2020-2031)
4.1.1 Global Radiopharmaceutical Sales by Type (2020-2025)
4.1.2 Global Radiopharmaceutical Sales by Type (2026-2031)
4.1.3 Global Radiopharmaceutical Sales Market Share by Type (2020-2031)
4.2 Global Radiopharmaceutical Revenue by Type (2020-2031)
4.2.1 Global Radiopharmaceutical Revenue by Type (2020-2025)
4.2.2 Global Radiopharmaceutical Revenue by Type (2026-2031)
4.2.3 Global Radiopharmaceutical Revenue Market Share by Type (2020-2031)
4.3 Global Radiopharmaceutical Price by Type (2020-2031)
5 Segment by Application
5.1 Global Radiopharmaceutical Sales by Application (2020-2031)
5.1.1 Global Radiopharmaceutical Sales by Application (2020-2025)
5.1.2 Global Radiopharmaceutical Sales by Application (2026-2031)
5.1.3 Global Radiopharmaceutical Sales Market Share by Application (2020-2031)
5.2 Global Radiopharmaceutical Revenue by Application (2020-2031)
5.2.1 Global Radiopharmaceutical Revenue by Application (2020-2025)
5.2.2 Global Radiopharmaceutical Revenue by Application (2026-2031)
5.2.3 Global Radiopharmaceutical Revenue Market Share by Application (2020-2031)
5.3 Global Radiopharmaceutical Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Cardinal Health
6.1.1 Cardinal Health Company Information
6.1.2 Cardinal Health Description and Business Overview
6.1.3 Cardinal Health Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Cardinal Health Radiopharmaceutical Product Portfolio
6.1.5 Cardinal Health Recent Developments/Updates
6.2 GE Healthcare
6.2.1 GE Healthcare Company Information
6.2.2 GE Healthcare Description and Business Overview
6.2.3 GE Healthcare Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GE Healthcare Radiopharmaceutical Product Portfolio
6.2.5 GE Healthcare Recent Developments/Updates
6.3 Jubilant Pharma
6.3.1 Jubilant Pharma Company Information
6.3.2 Jubilant Pharma Description and Business Overview
6.3.3 Jubilant Pharma Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Jubilant Pharma Radiopharmaceutical Product Portfolio
6.3.5 Jubilant Pharma Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Company Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novartis Radiopharmaceutical Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Curium Pharma
6.5.1 Curium Pharma Company Information
6.5.2 Curium Pharma Description and Business Overview
6.5.3 Curium Pharma Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Curium Pharma Radiopharmaceutical Product Portfolio
6.5.5 Curium Pharma Recent Developments/Updates
6.6 SIEMENS
6.6.1 SIEMENS Company Information
6.6.2 SIEMENS Description and Business Overview
6.6.3 SIEMENS Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
6.6.4 SIEMENS Radiopharmaceutical Product Portfolio
6.6.5 SIEMENS Recent Developments/Updates
6.7 Lantheus
6.7.1 Lantheus Company Information
6.7.2 Lantheus Description and Business Overview
6.7.3 Lantheus Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Lantheus Radiopharmaceutical Product Portfolio
6.7.5 Lantheus Recent Developments/Updates
6.8 Bracco Imaging
6.8.1 Bracco Imaging Company Information
6.8.2 Bracco Imaging Description and Business Overview
6.8.3 Bracco Imaging Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bracco Imaging Radiopharmaceutical Product Portfolio
6.8.5 Bracco Imaging Recent Developments/Updates
6.9 Bayer
6.9.1 Bayer Company Information
6.9.2 Bayer Description and Business Overview
6.9.3 Bayer Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Bayer Radiopharmaceutical Product Portfolio
6.9.5 Bayer Recent Developments/Updates
6.10 Eli Lilly
6.10.1 Eli Lilly Company Information
6.10.2 Eli Lilly Description and Business Overview
6.10.3 Eli Lilly Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Eli Lilly Radiopharmaceutical Product Portfolio
6.10.5 Eli Lilly Recent Developments/Updates
6.11 Aurobindo Pharma
6.11.1 Aurobindo Pharma Company Information
6.11.2 Aurobindo Pharma Description and Business Overview
6.11.3 Aurobindo Pharma Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Aurobindo Pharma Radiopharmaceutical Product Portfolio
6.11.5 Aurobindo Pharma Recent Developments/Updates
6.12 Mundipharma
6.12.1 Mundipharma Company Information
6.12.2 Mundipharma Description and Business Overview
6.12.3 Mundipharma Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Mundipharma Radiopharmaceutical Product Portfolio
6.12.5 Mundipharma Recent Developments/Updates
6.13 China Isotope & Radiation
6.13.1 China Isotope & Radiation Company Information
6.13.2 China Isotope & Radiation Description and Business Overview
6.13.3 China Isotope & Radiation Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
6.13.4 China Isotope & Radiation Radiopharmaceutical Product Portfolio
6.13.5 China Isotope & Radiation Recent Developments/Updates
6.14 Dongcheng
6.14.1 Dongcheng Company Information
6.14.2 Dongcheng Description and Business Overview
6.14.3 Dongcheng Radiopharmaceutical Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Dongcheng Radiopharmaceutical Product Portfolio
6.14.5 Dongcheng Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Radiopharmaceutical Industry Chain Analysis
7.2 Radiopharmaceutical Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Radiopharmaceutical Production Mode & Process Analysis
7.4 Radiopharmaceutical Sales and Marketing
7.4.1 Radiopharmaceutical Sales Channels
7.4.2 Radiopharmaceutical Distributors
7.5 Radiopharmaceutical Customer Analysis
8 Radiopharmaceutical Market Dynamics
8.1 Radiopharmaceutical Industry Trends
8.2 Radiopharmaceutical Market Drivers
8.3 Radiopharmaceutical Market Challenges
8.4 Radiopharmaceutical Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Radiopharmaceutical Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Radiopharmaceutical Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Radiopharmaceutical Market Competitive Situation by Manufacturers in 2024
Table 4. Global Radiopharmaceutical Sales (K Dose) of Key Manufacturers (2020-2025)
Table 5. Global Radiopharmaceutical Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Radiopharmaceutical Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Radiopharmaceutical Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Radiopharmaceutical Average Price (USD/Dose) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Radiopharmaceutical, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Radiopharmaceutical, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Radiopharmaceutical, Product Type & Application
Table 12. Global Key Manufacturers of Radiopharmaceutical, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Radiopharmaceutical by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Radiopharmaceutical Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Radiopharmaceutical Sales by Region (2020-2025) & (K Dose)
Table 18. Global Radiopharmaceutical Sales Market Share by Region (2020-2025)
Table 19. Global Radiopharmaceutical Sales by Region (2026-2031) & (K Dose)
Table 20. Global Radiopharmaceutical Sales Market Share by Region (2026-2031)
Table 21. Global Radiopharmaceutical Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Radiopharmaceutical Revenue Market Share by Region (2020-2025)
Table 23. Global Radiopharmaceutical Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Radiopharmaceutical Revenue Market Share by Region (2026-2031)
Table 25. North America Radiopharmaceutical Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Radiopharmaceutical Sales by Country (2020-2025) & (K Dose)
Table 27. North America Radiopharmaceutical Sales by Country (2026-2031) & (K Dose)
Table 28. North America Radiopharmaceutical Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Radiopharmaceutical Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Radiopharmaceutical Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Radiopharmaceutical Sales by Country (2020-2025) & (K Dose)
Table 32. Europe Radiopharmaceutical Sales by Country (2026-2031) & (K Dose)
Table 33. Europe Radiopharmaceutical Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Radiopharmaceutical Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Radiopharmaceutical Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Radiopharmaceutical Sales by Region (2020-2025) & (K Dose)
Table 37. Asia Pacific Radiopharmaceutical Sales by Region (2026-2031) & (K Dose)
Table 38. Asia Pacific Radiopharmaceutical Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Radiopharmaceutical Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Radiopharmaceutical Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Radiopharmaceutical Sales by Country (2020-2025) & (K Dose)
Table 42. Latin America Radiopharmaceutical Sales by Country (2026-2031) & (K Dose)
Table 43. Latin America Radiopharmaceutical Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Radiopharmaceutical Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Radiopharmaceutical Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Radiopharmaceutical Sales by Country (2020-2025) & (K Dose)
Table 47. Middle East and Africa Radiopharmaceutical Sales by Country (2026-2031) & (K Dose)
Table 48. Middle East and Africa Radiopharmaceutical Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Radiopharmaceutical Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Radiopharmaceutical Sales (K Dose) by Type (2020-2025)
Table 51. Global Radiopharmaceutical Sales (K Dose) by Type (2026-2031)
Table 52. Global Radiopharmaceutical Sales Market Share by Type (2020-2025)
Table 53. Global Radiopharmaceutical Sales Market Share by Type (2026-2031)
Table 54. Global Radiopharmaceutical Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Radiopharmaceutical Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Radiopharmaceutical Revenue Market Share by Type (2020-2025)
Table 57. Global Radiopharmaceutical Revenue Market Share by Type (2026-2031)
Table 58. Global Radiopharmaceutical Price (USD/Dose) by Type (2020-2025)
Table 59. Global Radiopharmaceutical Price (USD/Dose) by Type (2026-2031)
Table 60. Global Radiopharmaceutical Sales (K Dose) by Application (2020-2025)
Table 61. Global Radiopharmaceutical Sales (K Dose) by Application (2026-2031)
Table 62. Global Radiopharmaceutical Sales Market Share by Application (2020-2025)
Table 63. Global Radiopharmaceutical Sales Market Share by Application (2026-2031)
Table 64. Global Radiopharmaceutical Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Radiopharmaceutical Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Radiopharmaceutical Revenue Market Share by Application (2020-2025)
Table 67. Global Radiopharmaceutical Revenue Market Share by Application (2026-2031)
Table 68. Global Radiopharmaceutical Price (USD/Dose) by Application (2020-2025)
Table 69. Global Radiopharmaceutical Price (USD/Dose) by Application (2026-2031)
Table 70. Cardinal Health Company Information
Table 71. Cardinal Health Description and Business Overview
Table 72. Cardinal Health Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 73. Cardinal Health Radiopharmaceutical Product
Table 74. Cardinal Health Recent Developments/Updates
Table 75. GE Healthcare Company Information
Table 76. GE Healthcare Description and Business Overview
Table 77. GE Healthcare Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 78. GE Healthcare Radiopharmaceutical Product
Table 79. GE Healthcare Recent Developments/Updates
Table 80. Jubilant Pharma Company Information
Table 81. Jubilant Pharma Description and Business Overview
Table 82. Jubilant Pharma Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 83. Jubilant Pharma Radiopharmaceutical Product
Table 84. Jubilant Pharma Recent Developments/Updates
Table 85. Novartis Company Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 88. Novartis Radiopharmaceutical Product
Table 89. Novartis Recent Developments/Updates
Table 90. Curium Pharma Company Information
Table 91. Curium Pharma Description and Business Overview
Table 92. Curium Pharma Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 93. Curium Pharma Radiopharmaceutical Product
Table 94. Curium Pharma Recent Developments/Updates
Table 95. SIEMENS Company Information
Table 96. SIEMENS Description and Business Overview
Table 97. SIEMENS Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 98. SIEMENS Radiopharmaceutical Product
Table 99. SIEMENS Recent Developments/Updates
Table 100. Lantheus Company Information
Table 101. Lantheus Description and Business Overview
Table 102. Lantheus Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 103. Lantheus Radiopharmaceutical Product
Table 104. Lantheus Recent Developments/Updates
Table 105. Bracco Imaging Company Information
Table 106. Bracco Imaging Description and Business Overview
Table 107. Bracco Imaging Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 108. Bracco Imaging Radiopharmaceutical Product
Table 109. Bracco Imaging Recent Developments/Updates
Table 110. Bayer Company Information
Table 111. Bayer Description and Business Overview
Table 112. Bayer Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 113. Bayer Radiopharmaceutical Product
Table 114. Bayer Recent Developments/Updates
Table 115. Eli Lilly Company Information
Table 116. Eli Lilly Description and Business Overview
Table 117. Eli Lilly Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 118. Eli Lilly Radiopharmaceutical Product
Table 119. Eli Lilly Recent Developments/Updates
Table 120. Aurobindo Pharma Company Information
Table 121. Aurobindo Pharma Description and Business Overview
Table 122. Aurobindo Pharma Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 123. Aurobindo Pharma Radiopharmaceutical Product
Table 124. Aurobindo Pharma Recent Developments/Updates
Table 125. Mundipharma Company Information
Table 126. Mundipharma Description and Business Overview
Table 127. Mundipharma Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 128. Mundipharma Radiopharmaceutical Product
Table 129. Mundipharma Recent Developments/Updates
Table 130. China Isotope & Radiation Company Information
Table 131. China Isotope & Radiation Description and Business Overview
Table 132. China Isotope & Radiation Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 133. China Isotope & Radiation Radiopharmaceutical Product
Table 134. China Isotope & Radiation Recent Developments/Updates
Table 135. Dongcheng Company Information
Table 136. Dongcheng Description and Business Overview
Table 137. Dongcheng Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 138. Dongcheng Radiopharmaceutical Product
Table 139. Dongcheng Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Radiopharmaceutical Distributors List
Table 143. Radiopharmaceutical Customers List
Table 144. Radiopharmaceutical Market Trends
Table 145. Radiopharmaceutical Market Drivers
Table 146. Radiopharmaceutical Market Challenges
Table 147. Radiopharmaceutical Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Radiopharmaceutical
Figure 2. Global Radiopharmaceutical Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Radiopharmaceutical Market Share by Type: 2024 & 2031
Figure 4. Diagnostic Radiopharmaceuticals Product Picture
Figure 5. Therapeutic Radiopharmaceuticals Product Picture
Figure 6. Global Radiopharmaceutical Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Radiopharmaceutical Market Share by Application: 2024 & 2031
Figure 8. Oncology
Figure 9. Cardiology
Figure 10. Other
Figure 11. Global Radiopharmaceutical Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Radiopharmaceutical Market Size (2020-2031) & (US$ Million)
Figure 13. Global Radiopharmaceutical Sales (2020-2031) & (K Dose)
Figure 14. Global Radiopharmaceutical Average Price (USD/Dose) & (2020-2031)
Figure 15. Radiopharmaceutical Report Years Considered
Figure 16. Radiopharmaceutical Sales Share by Manufacturers in 2024
Figure 17. Global Radiopharmaceutical Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Radiopharmaceutical Players: Market Share by Revenue in Radiopharmaceutical in 2024
Figure 19. Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Radiopharmaceutical Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Radiopharmaceutical Sales Market Share by Country (2020-2031)
Figure 22. North America Radiopharmaceutical Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Radiopharmaceutical Sales Market Share by Country (2020-2031)
Figure 26. Europe Radiopharmaceutical Revenue Market Share by Country (2020-2031)
Figure 27. Germany Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Radiopharmaceutical Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Radiopharmaceutical Revenue Market Share by Region (2020-2031)
Figure 34. China Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Philippines Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Radiopharmaceutical Sales Market Share by Country (2020-2031)
Figure 45. Latin America Radiopharmaceutical Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Radiopharmaceutical Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Radiopharmaceutical Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. U.A.E Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Radiopharmaceutical by Type (2020-2031)
Figure 55. Global Revenue Market Share of Radiopharmaceutical by Type (2020-2031)
Figure 56. Global Radiopharmaceutical Price (USD/Dose) by Type (2020-2031)
Figure 57. Global Sales Market Share of Radiopharmaceutical by Application (2020-2031)
Figure 58. Global Revenue Market Share of Radiopharmaceutical by Application (2020-2031)
Figure 59. Global Radiopharmaceutical Price (USD/Dose) by Application (2020-2031)
Figure 60. Radiopharmaceutical Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Radiopharmaceutical Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Radiopharmaceutical Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Radiopharmaceutical Market Competitive Situation by Manufacturers in 2024
Table 4. Global Radiopharmaceutical Sales (K Dose) of Key Manufacturers (2020-2025)
Table 5. Global Radiopharmaceutical Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Radiopharmaceutical Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Radiopharmaceutical Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Radiopharmaceutical Average Price (USD/Dose) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Radiopharmaceutical, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Radiopharmaceutical, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Radiopharmaceutical, Product Type & Application
Table 12. Global Key Manufacturers of Radiopharmaceutical, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Radiopharmaceutical by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Radiopharmaceutical Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Radiopharmaceutical Sales by Region (2020-2025) & (K Dose)
Table 18. Global Radiopharmaceutical Sales Market Share by Region (2020-2025)
Table 19. Global Radiopharmaceutical Sales by Region (2026-2031) & (K Dose)
Table 20. Global Radiopharmaceutical Sales Market Share by Region (2026-2031)
Table 21. Global Radiopharmaceutical Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Radiopharmaceutical Revenue Market Share by Region (2020-2025)
Table 23. Global Radiopharmaceutical Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Radiopharmaceutical Revenue Market Share by Region (2026-2031)
Table 25. North America Radiopharmaceutical Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Radiopharmaceutical Sales by Country (2020-2025) & (K Dose)
Table 27. North America Radiopharmaceutical Sales by Country (2026-2031) & (K Dose)
Table 28. North America Radiopharmaceutical Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Radiopharmaceutical Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Radiopharmaceutical Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Radiopharmaceutical Sales by Country (2020-2025) & (K Dose)
Table 32. Europe Radiopharmaceutical Sales by Country (2026-2031) & (K Dose)
Table 33. Europe Radiopharmaceutical Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Radiopharmaceutical Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Radiopharmaceutical Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Radiopharmaceutical Sales by Region (2020-2025) & (K Dose)
Table 37. Asia Pacific Radiopharmaceutical Sales by Region (2026-2031) & (K Dose)
Table 38. Asia Pacific Radiopharmaceutical Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Radiopharmaceutical Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Radiopharmaceutical Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Radiopharmaceutical Sales by Country (2020-2025) & (K Dose)
Table 42. Latin America Radiopharmaceutical Sales by Country (2026-2031) & (K Dose)
Table 43. Latin America Radiopharmaceutical Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Radiopharmaceutical Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Radiopharmaceutical Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Radiopharmaceutical Sales by Country (2020-2025) & (K Dose)
Table 47. Middle East and Africa Radiopharmaceutical Sales by Country (2026-2031) & (K Dose)
Table 48. Middle East and Africa Radiopharmaceutical Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Radiopharmaceutical Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Radiopharmaceutical Sales (K Dose) by Type (2020-2025)
Table 51. Global Radiopharmaceutical Sales (K Dose) by Type (2026-2031)
Table 52. Global Radiopharmaceutical Sales Market Share by Type (2020-2025)
Table 53. Global Radiopharmaceutical Sales Market Share by Type (2026-2031)
Table 54. Global Radiopharmaceutical Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Radiopharmaceutical Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Radiopharmaceutical Revenue Market Share by Type (2020-2025)
Table 57. Global Radiopharmaceutical Revenue Market Share by Type (2026-2031)
Table 58. Global Radiopharmaceutical Price (USD/Dose) by Type (2020-2025)
Table 59. Global Radiopharmaceutical Price (USD/Dose) by Type (2026-2031)
Table 60. Global Radiopharmaceutical Sales (K Dose) by Application (2020-2025)
Table 61. Global Radiopharmaceutical Sales (K Dose) by Application (2026-2031)
Table 62. Global Radiopharmaceutical Sales Market Share by Application (2020-2025)
Table 63. Global Radiopharmaceutical Sales Market Share by Application (2026-2031)
Table 64. Global Radiopharmaceutical Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Radiopharmaceutical Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Radiopharmaceutical Revenue Market Share by Application (2020-2025)
Table 67. Global Radiopharmaceutical Revenue Market Share by Application (2026-2031)
Table 68. Global Radiopharmaceutical Price (USD/Dose) by Application (2020-2025)
Table 69. Global Radiopharmaceutical Price (USD/Dose) by Application (2026-2031)
Table 70. Cardinal Health Company Information
Table 71. Cardinal Health Description and Business Overview
Table 72. Cardinal Health Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 73. Cardinal Health Radiopharmaceutical Product
Table 74. Cardinal Health Recent Developments/Updates
Table 75. GE Healthcare Company Information
Table 76. GE Healthcare Description and Business Overview
Table 77. GE Healthcare Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 78. GE Healthcare Radiopharmaceutical Product
Table 79. GE Healthcare Recent Developments/Updates
Table 80. Jubilant Pharma Company Information
Table 81. Jubilant Pharma Description and Business Overview
Table 82. Jubilant Pharma Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 83. Jubilant Pharma Radiopharmaceutical Product
Table 84. Jubilant Pharma Recent Developments/Updates
Table 85. Novartis Company Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 88. Novartis Radiopharmaceutical Product
Table 89. Novartis Recent Developments/Updates
Table 90. Curium Pharma Company Information
Table 91. Curium Pharma Description and Business Overview
Table 92. Curium Pharma Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 93. Curium Pharma Radiopharmaceutical Product
Table 94. Curium Pharma Recent Developments/Updates
Table 95. SIEMENS Company Information
Table 96. SIEMENS Description and Business Overview
Table 97. SIEMENS Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 98. SIEMENS Radiopharmaceutical Product
Table 99. SIEMENS Recent Developments/Updates
Table 100. Lantheus Company Information
Table 101. Lantheus Description and Business Overview
Table 102. Lantheus Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 103. Lantheus Radiopharmaceutical Product
Table 104. Lantheus Recent Developments/Updates
Table 105. Bracco Imaging Company Information
Table 106. Bracco Imaging Description and Business Overview
Table 107. Bracco Imaging Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 108. Bracco Imaging Radiopharmaceutical Product
Table 109. Bracco Imaging Recent Developments/Updates
Table 110. Bayer Company Information
Table 111. Bayer Description and Business Overview
Table 112. Bayer Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 113. Bayer Radiopharmaceutical Product
Table 114. Bayer Recent Developments/Updates
Table 115. Eli Lilly Company Information
Table 116. Eli Lilly Description and Business Overview
Table 117. Eli Lilly Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 118. Eli Lilly Radiopharmaceutical Product
Table 119. Eli Lilly Recent Developments/Updates
Table 120. Aurobindo Pharma Company Information
Table 121. Aurobindo Pharma Description and Business Overview
Table 122. Aurobindo Pharma Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 123. Aurobindo Pharma Radiopharmaceutical Product
Table 124. Aurobindo Pharma Recent Developments/Updates
Table 125. Mundipharma Company Information
Table 126. Mundipharma Description and Business Overview
Table 127. Mundipharma Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 128. Mundipharma Radiopharmaceutical Product
Table 129. Mundipharma Recent Developments/Updates
Table 130. China Isotope & Radiation Company Information
Table 131. China Isotope & Radiation Description and Business Overview
Table 132. China Isotope & Radiation Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 133. China Isotope & Radiation Radiopharmaceutical Product
Table 134. China Isotope & Radiation Recent Developments/Updates
Table 135. Dongcheng Company Information
Table 136. Dongcheng Description and Business Overview
Table 137. Dongcheng Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 138. Dongcheng Radiopharmaceutical Product
Table 139. Dongcheng Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Radiopharmaceutical Distributors List
Table 143. Radiopharmaceutical Customers List
Table 144. Radiopharmaceutical Market Trends
Table 145. Radiopharmaceutical Market Drivers
Table 146. Radiopharmaceutical Market Challenges
Table 147. Radiopharmaceutical Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Radiopharmaceutical
Figure 2. Global Radiopharmaceutical Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Radiopharmaceutical Market Share by Type: 2024 & 2031
Figure 4. Diagnostic Radiopharmaceuticals Product Picture
Figure 5. Therapeutic Radiopharmaceuticals Product Picture
Figure 6. Global Radiopharmaceutical Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Radiopharmaceutical Market Share by Application: 2024 & 2031
Figure 8. Oncology
Figure 9. Cardiology
Figure 10. Other
Figure 11. Global Radiopharmaceutical Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Radiopharmaceutical Market Size (2020-2031) & (US$ Million)
Figure 13. Global Radiopharmaceutical Sales (2020-2031) & (K Dose)
Figure 14. Global Radiopharmaceutical Average Price (USD/Dose) & (2020-2031)
Figure 15. Radiopharmaceutical Report Years Considered
Figure 16. Radiopharmaceutical Sales Share by Manufacturers in 2024
Figure 17. Global Radiopharmaceutical Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Radiopharmaceutical Players: Market Share by Revenue in Radiopharmaceutical in 2024
Figure 19. Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Radiopharmaceutical Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Radiopharmaceutical Sales Market Share by Country (2020-2031)
Figure 22. North America Radiopharmaceutical Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Radiopharmaceutical Sales Market Share by Country (2020-2031)
Figure 26. Europe Radiopharmaceutical Revenue Market Share by Country (2020-2031)
Figure 27. Germany Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Radiopharmaceutical Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Radiopharmaceutical Revenue Market Share by Region (2020-2031)
Figure 34. China Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Philippines Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Radiopharmaceutical Sales Market Share by Country (2020-2031)
Figure 45. Latin America Radiopharmaceutical Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Radiopharmaceutical Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Radiopharmaceutical Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. U.A.E Radiopharmaceutical Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Radiopharmaceutical by Type (2020-2031)
Figure 55. Global Revenue Market Share of Radiopharmaceutical by Type (2020-2031)
Figure 56. Global Radiopharmaceutical Price (USD/Dose) by Type (2020-2031)
Figure 57. Global Sales Market Share of Radiopharmaceutical by Application (2020-2031)
Figure 58. Global Revenue Market Share of Radiopharmaceutical by Application (2020-2031)
Figure 59. Global Radiopharmaceutical Price (USD/Dose) by Application (2020-2031)
Figure 60. Radiopharmaceutical Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Electrolytes for Lithium-Ion Batteries Market Research Report 2025
Jul 14, 25
Global Vanadium Products Market Research Report 2025
Jul 14, 25
Global High-purity Vanadium Oxide Market Research Report 2025
Jul 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232